Logo Image
News
All NewsAAP NewsPNP Corner
Media
Clinical Forum InsightsCure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsShortsSpecial ReportsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardProduct ProfileSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Hidradenitis Suppurativa
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Central Precocious Puberty
  • Gastroenterology
    • Formula
    • Obesity
  • Genetic Disorders
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • RSV
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • Nutrition
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Rare Disease
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement

Eveline Y. Wu, MD, MSCR

Advertisement

Eveline Y. Wu, MD, MSCR, is division chief, Department of Pediatric Rheumatology, The University of North Carolina at Chapel Hill.

Articles by Eveline Y. Wu, MD, MSCR

Biologics to the rescue | Image Credit: © Nadzeya - © Nadzeya - stock.adobe.com

Biologics to the rescue: changing the treatment paradigm in juvenile idiopathic arthritis

ByAlice Pan, PharmD,Eveline Y. Wu, MD, MSCR,Laura Cannon, MD
April 14th 2023

The introduction of novel biologic agents has revolutionized the treatment of the disease in recent years.

Advertisement

Latest Updated Articles

  • Biologics to the rescue | Image Credit: © Nadzeya - © Nadzeya - stock.adobe.com
    Biologics to the rescue: changing the treatment paradigm in juvenile idiopathic arthritis

    April 14th 2023



Advertisement
Advertisement

Trending on Contemporary Pediatrics

1

What Pediatricians Should Know About JAK Inhibitors Before Referral

2

Building trust may be key to vaccine conversations with hesitant families

3

Vaccine schedule overhaul raises concerns about delayed protection and access, says Ravi Jhaveri, MD

4

Back-to-school vaccinations: What pediatricians need to know for the back-to-school season

5

Eczema, delayed allergen introduction, and early antibiotics top list of childhood food allergy risk factors

  • About Us
  • Advertise
  • Contact Us
  • Editorial
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us